trial · primary record
BL-M14D1
Extensive-stage Small-cell Lung Cancer
| Phase | Phase 2 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 36 |
| Primary completion | 2027-12 |
| Primary endpoint | Objective Response Rate (ORR) |
| Registry ID | NCT07654400 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-11-02T15:44:56.214Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT07654400
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.
Same entity, elsewhere in the suite
- Bl-m14d1 · compound